Psychometric Properties of a Short Self-reported Measure of Medication Adherence Among Patients with Hypertension Treated in a Busy Clinical Setting in Korea
Overview
Authors
Affiliations
Background: We examined the psychometric properties of the Korean version of the 8-item Morisky Medication Adherence Scale (MMAS-8) among adults with hypertension.
Methods: A total of 373 adults with hypertension were given face-to-face interviews in 2 cardiology clinics at 2 large teaching hospitals in Seoul, South Korea. Blood pressure was measured twice, and medical records were reviewed. About one-third of the participants (n = 109) were randomly selected for a 2-week test-retest evaluation of reliability via telephone interview.
Results: Internal consistency reliability was moderate (Cronbach α = 0.56), and test-retest reliability was excellent (intraclass correlation = 0.91; P < 0.001), although a ceiling effect was detected. The correlation of MMAS-8 scores with scores for the original 4-item scale indicated that convergent validity was good (r = 0.92; P < 0.01). A low MMAS-8 score was significantly associated with poor blood pressure control (χ(2) = 29.86; P < 0.001; adjusted odds ratio = 5.08; 95% CI, 2.56-10.08). Using a cut-off point of 6, sensitivity and specificity were 64.3% and 72.9%, respectively. Exploratory factor analysis identified 3 dimensions of the scale, with poor fit for the 1-dimensional construct using confirmatory factory analysis.
Conclusions: The MMAS-8 had satisfactory reliability and validity and thus might be suitable for assessment and counseling regarding medication adherence among adults with hypertension in a busy clinical setting in Korea.
Adisa R, Ufuah U, Ige O BMC Health Serv Res. 2024; 24(1):1199.
PMID: 39379970 PMC: 11460063. DOI: 10.1186/s12913-024-11683-9.
Bae M, Song H Iran J Public Health. 2024; 53(5):1058-1067.
PMID: 38912149 PMC: 11188641. DOI: 10.18502/ijph.v53i5.15586.
Oliveira H, Hayashi D, Carvalho S, Barros R, Neves M, Andrechuk C Syst Rev. 2023; 12(1):222.
PMID: 37993931 PMC: 10664314. DOI: 10.1186/s13643-023-02340-z.
Marques M, Pedrosa R, Oliveira H, Gallani M, Rodrigues R Pharmacol Res Perspect. 2023; 11(6):e01113.
PMID: 37897150 PMC: 10611946. DOI: 10.1002/prp2.1113.
Tegegn H, Wark S, Tursan dEspaignet E, Spark M Clin Drug Investig. 2022; 42(11):879-908.
PMID: 36180813 PMC: 9617955. DOI: 10.1007/s40261-022-01199-7.